4sight Health November 6, 2024
David Burda

It’s time for another installment of my healthcare blame game series. The series is based on my theory that sectors of the healthcare industry take turns blaming each other for high costs, limited access and poor quality while tacitly agreeing amongst themselves not to really do anything about it.

This segment is brought to you by Big Pharma, which is blaming primarily health insurers, and to a lesser extent providers, for consumer access problems.

The blame is embodied in a report called Access Denied: Patients Speak Out on Insurance Barriers and the Need for Policy Change. The 28-page report is based on a survey of about 2,600 U.S. adults age 18 or older conducted by Ipsos (the market research firm)...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin
What might a Trump administration mean for the Biosecure Act?

Share This Article